$1.55
0.000.00%
At close: -
$1.55
0.000.00%
After Hours: Apr 11, 4:04 PM EDT
Comments
Loading...
Aprea Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:APRE | Benzinga
Aprea Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 25
EPS
$-0.490
Quarterly Revenue
$205.82K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Aprea Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| APRE | Aprea Therapeutics | -$0.67 | — | — | — | $380.57K | — | — | — | 05/13/2025 | Get Alert |
| APRE | Aprea Therapeutics | -$0.92 | -$0.68 | -$0.49 | 27.94% | $14.07K | $450.00K | $205.82K | -54.26% | 03/25/2025 | Get Alert |
| APRE | Aprea Therapeutics | -$0.86 | -$0.72 | -$0.64 | 11.11% | $319.47K | $225.00K | $354.62K | 57.61% | 11/07/2024 | Get Alert |
| APRE | Aprea Therapeutics | -$0.87 | -$0.64 | -$0.58 | 9.38% | $249.69K | $50.00K | $561.57K | 1023.15% | 08/12/2024 | Get Alert |
| APRE | Aprea Therapeutics | -$1.34 | -$0.78 | -$0.67 | 14.10% | $0.00 | — | $380.57K | — | 05/14/2024 | Get Alert |
| APRE | Aprea Therapeutics | -$0.92 | -$0.77 | -$0.92 | -19.48% | $0.00 | $110.00K | $14.07K | -87.20% | 03/26/2024 | Get Alert |
| APRE | Aprea Therapeutics | -$2.40 | -$1.16 | -$0.86 | 25.86% | $0.00 | $80.00K | $319.47K | 299.34% | 11/09/2023 | Get Alert |
| APRE | Aprea Therapeutics | -$19.80 | -$1.42 | -$0.87 | 38.73% | $0.00 | — | $249.69K | — | 08/10/2023 | Get Alert |
| APRE | Aprea Therapeutics | -$7.20 | — | -$1.34 | — | $0.00 | — | $0.00 | — | 05/15/2023 | Get Alert |
| APRE | Aprea Therapeutics | -$7.20 | -$2.60 | -$0.92 | 64.62% | $0.00 | — | $0.00 | — | 03/30/2023 | Get Alert |
| APRE | Aprea Therapeutics | -$9.00 | -$5.40 | -$2.40 | 55.56% | $0.00 | — | $0.00 | — | 11/09/2022 | Get Alert |
| APRE | Aprea Therapeutics | -$9.60 | -$7.40 | -$19.80 | -167.57% | $0.00 | — | $0.00 | — | 08/12/2022 | Get Alert |
| APRE | Aprea Therapeutics | -$9.20 | -$7.60 | -$7.20 | 5.26% | $0.00 | — | $0.00 | — | 05/16/2022 | Get Alert |
| APRE | Aprea Therapeutics | -$14.60 | -$8.80 | -$7.20 | 18.18% | $0.00 | — | $0.00 | — | 03/15/2022 | Get Alert |
| APRE | Aprea Therapeutics | -$11.60 | -$8.80 | -$9.00 | -2.27% | $0.00 | — | $0.00 | — | 11/08/2021 | Get Alert |
| APRE | Aprea Therapeutics | -$15.60 | -$9.60 | -$9.60 | 0.00% | $0.00 | — | $0.00 | — | 08/12/2021 | Get Alert |
| APRE | Aprea Therapeutics | -$9.00 | -$9.80 | -$9.20 | 6.12% | $0.00 | — | $0.00 | — | 05/06/2021 | Get Alert |
| APRE | Aprea Therapeutics | -$12.80 | — | -$14.60 | — | $0.00 | — | $0.00 | — | 03/16/2021 | Get Alert |
| APRE | Aprea Therapeutics | -$105.80 | — | -$11.60 | — | $0.00 | — | $0.00 | — | 11/05/2020 | Get Alert |
| APRE | Aprea Therapeutics | -$89.00 | — | -$15.60 | — | — | — | $0.00 | — | 08/11/2020 | Get Alert |
| APRE | Aprea Therapeutics | -$59.40 | — | -$9.00 | — | — | — | $0.00 | — | 05/15/2020 | Get Alert |
Aprea Therapeutics (APRE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-25 | $-0.49 | $-0.68 | 27.9 % |
| Q3 | 2024-11-07 | $-0.64 | $-0.72 | 11.1 % |
| Q2 | 2024-08-12 | $-0.58 | $-0.64 | 9.38 % |
| Q1 | 2024-05-14 | $-0.67 | $-0.78 | 14.1 % |
Aprea Therapeutics (APRE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-25 | $205.82K | $450.00K | -54.3 % |
| Q3 | 2024-11-07 | $354.62K | $225.00K | 57.6 % |
| Q2 | 2024-08-12 | $561.57K | $50.00K | 1023.2 % |
| Q4 | 2024-03-26 | $14.08K | $110.00K | -87.2 % |
FAQ
When is Aprea Therapeutics (NASDAQ:APRE) reporting earnings?
Aprea Therapeutics (APRE) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on March 25, 2025 for Q4.
What were the latest earnings per share (EPS) for Aprea Therapeutics (NASDAQ:APRE)?
The Actual EPS was $-0.49, which beat the estimate of $-0.68.
What were Aprea Therapeutics’s (NASDAQ:APRE) revenues?
The Actual Revenue was $205.8K, which missed the estimate of $450K.
Browse earnings estimates, EPS, and revenue on all stocks.